Bachelor's in Biomedicine

Lund University is a prestigious institution founded in 1666 and consistently ranked among the top 100 universities in the world. With approximately 45,000 students and 8,600 staff across its campuses in Lund, Helsingborg, Malmö, and Ljungbyhed, the university is committed to advancing our understanding of the world and improving the human condition through research and education. The university community is united in its dedication to excellence, innovation, and social responsibility.

Are you interested in the functions of the human body and want to contribute to reduce disease and suffer? Would you like to find a cure against diseases such as cancer and diabetes? Would you like to have an education that combines medicine and science with practical skills and applications? In that case, biomedicine is for you. You will be tutored by active research scientists, some of them world leading in their fields. You will be part of a research environment from the very beginning and take part of the latest techniques and research results.

Lund University is one of the most popular places to study in Sweden, offering one of the broadest ranges of programmes and courses in Scandinavia. With a focus on cross-disciplinary and cutting-edge research, the university provides excellent conditions for scientific breakthroughs and innovations, encouraging collaborations within academia and with society at large. The university has a strong international profile, with partner universities in some 75 countries. Lund University has an annual turnover of EUR 900 million, two-thirds of which is spent on research in its nine faculties and one-third on education. The university provides education and research in areas such as economics and management, engineering and technology, fine arts, music and theatre, humanities and theology, law, medicine, science, and social sciences. Lund University is home to two world-leading research facilities, the synchrotron radiation facility MAX IV and the European Spallation Source (ESS), which will be fully operational by the end of 2027. The university is committed to creating an international hub for research, education, and innovation in which it plays a central role.